Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$27.4M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 13 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 19 most recent Form 4 transactions.
| Open the original filing on SEC.gov |
| Aug 19 | RPRX | Royalty Pharma plc | GGIFT◷ | 16,800 | — | — | -42.0% | Open the original filing on SEC.gov |
| Aug 18 | RPRX | Royalty Pharma plc | SSELL◷ | 100,000 | $59.97 | $6M | -21.3% | Open the original filing on SEC.gov |
| Aug 5 | RPRX | Royalty Pharma plc | AGRANT | 11,002 | — | — | +2.4% | Open the original filing on SEC.gov |
| Jun 30 | RPRX | Royalty Pharma plc | SSELL◷ | 600 | $57.09 | $34.3K | -1.5% | Open the original filing on SEC.gov |
| Jun 30 | RPRX | Royalty Pharma plc | SSELL◷ | 29,400 | $56.44 | $1.7M | -42.0% | Open the original filing on SEC.gov |
| Jun 30 | RPRX | Royalty Pharma plc | SSELL◷ | 2,554 | $57.10 | $145.8K | -0.5% | Open the original filing on SEC.gov |
| Jun 30 | RPRX | Royalty Pharma plc | SSELL◷ | 97,446 | $56.50 | $5.5M | -17.4% | Open the original filing on SEC.gov |
| Jun 23 | RPRX | Royalty Pharma plc | SSELL◷ | 117,592 | $54.47 | $6.4M | -17.4% | Open the original filing on SEC.gov |
| Jun 23 | RPRX | Royalty Pharma plc | SSELL◷ | 32,408 | $54.11 | $1.8M | -4.6% | Open the original filing on SEC.gov |
| May 6 | RPRX | Royalty Pharma plc | AGRANT | 24,263 | — | — | +3.5% | Open the original filing on SEC.gov |
| Apr 16 | KLRA | Kailera Therapeutics, Inc. | AGRANT◆ | 38,300 | — | — | — | Open the original filing on SEC.gov |
| Mar 5 | VERA | Vera Therapeutics, Inc. | AGRANT◆ | 24,937 | — | — | — | Open the original filing on SEC.gov |
| Feb 11 | RPRX | Royalty Pharma plc | AGRANT | 26,626 | — | — | +4.0% | Open the original filing on SEC.gov |
| Nov 5, 2025 | RPRX | Royalty Pharma plc | AGRANT | 6,168 | — | — | +0.9% | Open the original filing on SEC.gov |
| Aug 6, 2025 | RPRX | Royalty Pharma plc | AGRANT | 3,696 | — | — | +0.6% | Open the original filing on SEC.gov |
| May 16, 2025 | RPRX | Royalty Pharma plc | AGRANT◆ | 1.2M | — | — | — | Open the original filing on SEC.gov |
| May 8, 2025 | RPRX | Royalty Pharma plc | AGRANT | 48,646 | — | — | +8.1% | Open the original filing on SEC.gov |